Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Viemed Healthcare, Inc. (VMD : NSDQ)

• Company Description    Viemed Healthcare Inc. is a home medical equipment supplier which provides post-acute respiratory care services through its subsidiaries Sleep Management L.L.C. and Home Sleep Delivered L.L.C. Viemed Healthcare Inc. is based in Lafayette, United States. Number of Employees: 1,179

• Price / Volume Information    Yesterday's Closing Price: $6.37 Daily Weekly Monthly 20 Day Moving Average: 161,443 shares Shares Outstanding: 38.02 (millions) Market Capitalization: $242.17 (millions) Beta: 1.29 52 Week High: $9.77 52 Week Low: $5.93 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -6.60% -9.05% 12 Week -7.55% -11.38% Year To Date -20.57% -30.57%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 625 East Kaliste Saloom Road - Lafayette,LA 70508 USA ph: 337-504-3802 fax: - glen@bristolir.com http://www.viemed.com

• General Corporate Information    Officers Casey Hoyt - Chief Executive Officer Randy Dobbs - Chairman W. Todd Zehnder - Chief Operating Officer Trae Fitzgerald - Chief Financial Officer William Frazier - Director Peer Information Viemed Healthcare, Inc. (BJCT) Viemed Healthcare, Inc. (CADMQ) Viemed Healthcare, Inc. (APNO) Viemed Healthcare, Inc. (UPDC) Viemed Healthcare, Inc. (IMTIQ) Viemed Healthcare, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 92663R105 SIC: 8090 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/09/26 Share - Related Items Shares Outstanding: 38.02 Most Recent Split Date: (:1) Beta: 1.29 Market Capitalization: $242.17 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/09/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 19.30 PEG Ratio: - Price Ratios Price/Book: 1.82 Price/Cash Flow: 6.77 Price / Sales: 0.95 EPS Growth vs. Year Ago Period: -10.00% vs. Previous Quarter: 12.50% Sales Growth vs. Year Ago Period: 23.98% vs. Previous Quarter: 14.05% ROE 09/30/25 - 9.95 06/30/25 - 10.38 03/31/25 - 9.49 ROA 09/30/25 - 7.34 06/30/25 - 7.88 03/31/25 - 7.14 Current Ratio 09/30/25 - 1.13 06/30/25 - 1.48 03/31/25 - 1.38 Quick Ratio 09/30/25 - 1.01 06/30/25 - 1.37 03/31/25 - 1.26 Operating Margin 09/30/25 - 5.34 06/30/25 - 5.80 03/31/25 - 5.28 Net Margin 09/30/25 - 5.34 06/30/25 - 5.80 03/31/25 - 5.28 Pre-Tax Margin 09/30/25 - 7.88 06/30/25 - 8.48 03/31/25 - 7.61 Book Value 09/30/25 - 3.49 06/30/25 - 3.58 03/31/25 - 3.46 Inventory Turnover 09/30/25 - 23.30 06/30/25 - 22.99 03/31/25 - 21.89 Debt-to-Equity 09/30/25 - 0.14 06/30/25 - 0.02 03/31/25 - 0.03 Debt-to-Capital 09/30/25 - 12.63 06/30/25 - 2.39 03/31/25 - 2.52

Powered by Zacks Investment Research ©